90221-50-4

Basic information

• Product Name: N-(2-BROMO-5-NITROPHENYL)ACETAMIDE
• Synonyms: N-(2-BROMO-5-NITROPHENYL)ACETAMIDE;RTSTZQRSWJGBNU-UHFFFAOYSA-N
• CAS NO: 90221-50-4
• Molecular Formula: C₈H₇BrN₂O₃
• Molecular Weight: 259.06
• Mol File: 90221-50-4.mol
• Article Data: 17

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-(2-BROMO-5-NITROPHENYL)ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-BROMO-5-NITROPHENYL)ACETAMIDE(90221-50-4)
• EPA Substance Registry System: N-(2-BROMO-5-NITROPHENYL)ACETAMIDE(90221-50-4)

Safety Data

• Hazardous Substances Data: 90221-50-4(Hazardous Substances Data)

Upstream product

• 99-09-2 3-nitro-aniline 
• 60-29-7 diethyl ether 
• 10026-13-8 phosphorus pentachloride 
• 54582-26-2 α-6-bromo-3-nitro-acetophenone oxime 
• 10403-47-1 2-bromo 5-nitroaniline 
• 75-36-5 acetyl chloride 
• 64-19-7 acetic acid 
• 108-24-7 acetic anhydride 

Downstream Products

• 21762-74-3 6-nitro-3,4-dihydro-3-oxo-2H(1,4)benzothiazine 
• 2941-66-4 2-methyl-5-nitrobenzothiazole 
• 453562-67-9 N-(2-bromo-5-nitrophenyl)-N-(2-methylprop-2-enyl)-acetamide 
• 453562-71-5 1-(6-amino-3,3-dimethyl-2,3-dihydroindol-1-yl)ethanone 
• 32046-51-8 2-methyl-5-nitro-1,3-benzoxazole 
• 38463-33-1 2-Methylthiazolochinolin 
• 13382-43-9 2-methyl-5-aminobenzothiazole 
• 116529-42-1 2-bromo-4,5-dinitro-aniline 
• 453562-68-0 1-(3,3-dimethyl-6-nitro-2,3-dihydro-indol-1-yl)-ethanone 
• 68867-15-2 N-(2-methyl-1,3-benzothiazol-5-yl)acetamide 

Relevant articles and documents

Synthesis of dibenzothiophene, dibenzofuran and carbazole donor-acceptor chromophores

We present efficient synthetic protocols for functionalizing dibenzothiophene, dibenzofuran, and carbazole with hydroxy and nitro or cyano groups. The synthesis of these donor-acceptor chromophores is based on a key Suzuki-Miyaura coupling using an approp

Iridium-catalyzed intramolecular C–N and C–O/S cross-coupling reactions: Preparation of benzoazole derivatives

The irdium-catalyzed intramolecular arylcarbon-hetero cross-coupling reactions with o-haloarylamides or o-haloarylamidine have been effectively achieved using KOAc and just 1 mol% catalyst. The [Ir(cod)Cl]2 was proved to be more potential for smoothly assembling functional structures benzimidazoles, benzoxazoles and benzothiazoles, which was superior to Cu- and Pd-catalyzed systems. Simultaneously, a concise and efficient synthesis of tafamidis was developed in 5-g scale.

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.